The Orange County Chapter of the ASA is excited to host its 2023 Annual Orange County Biostatistics Symposium on 29-30 Sep 2023. The theme of the 2-day Symposium is innovative designs in expediting drug and device development. The Symposium offers a great opportunity to hear from leading statistical and pharmaceutical/medical device experts from industry, academics and regulatory agencies on their experience and practice of bringing innovation to the development of drugs and devices. The symposium focuses on topics related to recent advances in methodology and applications related to complex innovation trial design, master protocols, gene and cell therapy, real-world evidence-based research. The Symposium also focuses on recent advances in the application of AI/ML methodologies in drug development. In addition, we are bringing academic researchers and students to present their research on the above topics.
Who should attend:
Statisticians, Statistical Analysts/Programmers, Clinical Research Professionals, Clinical Trial personnel, Regulatory Affairs associates, academic researchers, students, or anyone interested in learning more about drug development and regulatory aspects.
For more information, visit 2023 OC Symposium
Key speakers (Tentative):
- Harpreet Singh MD, CDER/FDA
- Narimon Honarpour MD, Amgen
- Zhenming Shun PhD, Daiichi Sankyo
- Aditya Rajagopal, Chromacode/Espertive Medical
- Jaime Wheeler, Edwards Lifesciences
- Arsela Prelaj MD, Istituto Nazionale Tumori di Milano, Italy
Venue: Edwards Lifesciences Conference Center, 1 Edwards Way, Irvine, CA 92612
Agenda:
Day 1:
- 8 AM – 12 Noon – Keynote session and panel discussions
- 1-5 PM – Parallel tracks of topics in clinical/statistics and data science/analytics
- Student posters (entire day)
- 5:30 to 7 PM – Evening reception
Day 2:
- 8 AM – 12 Noon – Keynote session and panel discussions
- 1-5 PM – Parallel tracks of topics in clinical/statistics and data science/analytics
- Student posters (entire day)
Sessions and Topics:
- Global view of the drug development – opportunities and challenges
- Real-world evidence-based development and health technology
- Application of AI/ML in drug development methodology
- Adaptive design based clinical trials – case studies
- Bayesian methodology – case studies
- Medical device and diagnostic product evaluation
- Application of statistical analysis and regulatory submissions
- Advanced statistical methodology in biomedical sciences
- Analytical tools and methods in clinical trial reporting
- Opportunities for new graduates and changes in life science dynamics – Panel discussion
Registration: Registration is open, please click the below link to register. Early bird registration ends on 15 Aug 2023.
https://2023ocbiostatistics.eventbee.com
Please contact me at gajbhat@gmail.com should you have any questions.
Sincerely,
Gajanan Bhat
Chair, 2023 OC Biostatistics Symposium Committee
------------------------------
Gajanan Bhat, PhD
Chair, Section on Biopharmaceutical Statistics, OCLBASA
Senior Vice President, Clinical Science, Spectrum Pharmaceuticals
------------------------------